
Cricef SB 250mg/125mg Injection
Marketer
Stride Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cricef SB 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg), a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and preventing infection spread. Administration must be under a doctor's guidance; strict adherence to the prescribed dosage and schedule is crucial for optimal efficacy. Premature cessation may compromise treatment. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for faster recovery. Monitoring may involve laboratory tests to assess treatment response.
Primary Ingredients of Cricef SB 250mg/125mg Injection
There is no text provided to rephrase.
Uses of Cricef SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cricef SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cricef SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cricef SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cricef SB 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cricef SB 250mg/125mg Injection, offer a powerful antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Sulbactam, a beta-lactamase inhibitor, complements this action by countering bacterial enzymes that would otherwise deactivate Ceftriaxone, thus maximizing its effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Cricef SB 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Cricef SB, containing 250mg/125mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are currently scarce.
Breast feedingCAUTION
Administering Cricef SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Cricef SB 250mg/125mg Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cricef SB 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should use Cricef SB 250mg/125mg Injection cautiously, potentially requiring dosage modification. Mild to moderate liver dysfunction does not necessitate Cricef SB 250mg/125mg Injection dose alteration; however, physician consultation is advised.
What if you forget to take Cricef SB 250mg/125mg Injection :
Should you forget a scheduled dose of Cricef SB 250mg/125mg Injection, seek medical advice.
Facts to Know About Cricef SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
